The FDA has classified the recall of some angiographic guidewires made by Medtronic (NYSE:MDT) as Class I, the most serious kind. Medtronic’s angiographic guidewire component affected by the recall helps place catheters into the vasculature during angiography or other interventional procedures. The recall occurred because of a lack of sterilization before shipment to hospitals, according […]
Medtronic
MedTech 100 roundup: New all-time best reached
Once again, the medtech industry has soared to new heights, eclipsing its all-time best performance by the tiniest of margins. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished the week (July 2) at 114.59 points. It was just 0.01 points ahead of the 114.58-point mark set in […]
Medtronic announces executive leadership changes
Medtronic (NYSE:MDT) today confirmed two personnel moves within its executive leadership team, with one retirement and a new appointment. SVP, general counsel and corporate secretary Bradley E. Lerman will retire, having notified the board of directors on June 24 that he planned to step down effective Dec. 31, 2021, according to an SEC filing. Lerman […]
Medtronic launches its first app-based research study
Medtronic (NYSE:MDT) today announced that it has initiated the Define AFib app-based research study.— a first of its kind for the company. The medtech giant will conduct the atrial fibrillation (AFib) study remotely using data collected from its Linq family of insertable cardiac monitors (ICM) on its Medtronic Discovery App. The goal is to address questions […]
Medtronic breaks ground on $200M campus in Colorado
Medtronic (NYSE:MDT) broke ground today on a new 400,000 ft2 innovation campus in Lafayette, Colo. The plan is for roughly 1,100 R&D and administrative employees at the medtech giant’s Boulder and Louisville facilities to move in by the end of next year. Manufacturing will stay in Boulder and Louisville. Medtronic businesses with operations in Colorado […]
DTW Weekly Podcast – Digging Deeper into Cleerly Health’s $43 million round
In this week’s DeviceTalks Weekly Podcast, we talk with Dr. James Min, the founder and CEO of Cleerly Health, a potentially disruptive diagnostics company that raised $43 million last week. Min explains how Cleerly Health formed from his work at Weill Cornell Medicine. But, more importantly, for entrepreneurs and executives, he walks listeners through the […]
7 companies using robot-assisted surgery to transform orthopedics
It seems as if every orthopedic device company is getting involved in robot-assisted surgery — rolling out robots to assist surgeons operating on the knee, hip, shoulder or spine. Two events in recent years especially signaled that robots were coming into their own in the space: Stryker spent $1.7 billion for Mako Surgical in order […]
Medtronic touts trial results for InPen smart insulin pen, extended infusion system
Medtronic (NYSE:MDT) today presented positive study results for its InPen smart insulin pen and its extended-wear infusion set. Fridley, Minn.-based Medtronic touted real-world clinical results comparing glycemic outcomes for 1,736 individuals before and after using the InPen smart insulin pen for 90 days with a continuous glucose monitor (CGM). Get the full story at our […]
MedTech 100 roundup: Nearing new highs once again
Having hit a downturn as the summer neared, the medtech industry is now consistently on the rise as June comes to a close. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished the week (June 25) at 113.42 points, producing a 2.5% rise from the 110.64-point mark set […]
Medtronic warns on Linq II insertable cardiac monitoring systems
Medtronic (NYSE:MDT) recently issued a warning letter regarding an issue with its Linq II insertable cardiac monitors (ICMs). Fridley, Minn.-based Medtronic’s warning informs users that Linq II ICMs that undergo a partial electrical reset appear to be programmed “ON,” but are no longer able to detect and report Brady, Pause and PVC events to clinicians. […]
Supreme Court rejects Medtronic bid to overturn spine surgeon’s royalties win
Medtronic (NYSE:MDT) lost its bid Monday to have the U.S. Supreme Court toss a decision awarding $112 million in royalties to an Indiana spine surgeon-turned-inventor. The court declined to hear a petition by Medtronic to overturn an appeals court decision that allowed the jury’s award to Dr. Rick Sasso to stand. Sasso won the royalties decision in […]
